MedPath

广东太安堂药业股份有限公司

🇨🇳China
Ownership
-
Established
2000-03-25
Employees
-
Market Cap
-
Website
www.tatonline.net

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

167

NMPA:166
NPRA:1

Drug Approvals

冠心康胶囊

Approval Number
国药准字Z20090275
Approval Date
Nov 8, 2023
NMPA

痔瘘舒丸

Approval Number
国药准字Z20083454
Approval Date
Sep 25, 2023
NMPA

保和丸

Approval Number
国药准字Z44022832
Approval Date
Aug 4, 2023
NMPA

理中丸

Approval Number
国药准字Z44023780
Approval Date
Aug 4, 2023
NMPA

桂附理中丸

Approval Number
国药准字Z44023606
Approval Date
Aug 4, 2023
NMPA

牛黄解毒丸

Approval Number
国药准字Z44023609
Approval Date
Aug 4, 2023
NMPA

壮腰健肾丸

Approval Number
国药准字Z44022498
Approval Date
Aug 4, 2023
NMPA

壮骨酒

Approval Number
国药准字Z44023614
Approval Date
Aug 4, 2023
NMPA

橘红丸

Approval Number
国药准字Z44023590
Approval Date
Aug 4, 2023
NMPA

银翘解毒丸

Approval Number
国药准字Z44023613
Approval Date
Aug 4, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 17
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.